glp 1 drugs kidney disease SGLT2 vs GLP-1 for CKD: Which Is Better? GLP-1 receptor agonist versus DPP-4
Description
Obesity Prevention and Management
doi: 10.1007/s00125-009-1643-x 33 AslamMLadilovY
Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages
Several studies have reported its antioxidant, anti-inflammatory, and lipid-lowering properties, suggesting potential applications in managing metabolic disorders [3,4,5]
